AYUSH
25-November, 2016 14:39 IST
Research about the Benefits of Medicines Made from Cow Urine in Chronic Diseases
Council of Scientific and Industrial Research (CSIR) through its constituent laboratories has conducted research studies in collaboration with Go Vigyan Anusandhan Kendra, Nagpur on cow urine distillate for its antioxidant and bio-enhancing properties on anti- infective and anti-cancer agents and nutrients. Four US Patents have been secured since 2002 and one pharmaceutical product containing cow urine distillate with anti-oxidant property is available in the market.
Panchagavya is a classic collective name of five products obtained from cow viz milk, curd, ghee, urine and dung. Cow urine is ingredient of several Ayurvedic formulations and also used as adjuvant with medicinal formulations and for pharmaceutical processing called Shodhana (Purification) and Bhavana (Triturition) of medicinal materials.
Panchagavya and its ingredients are part of the course curricula of Ayurvedic studies at degree and post-graduation levels. Opportunities of postgraduate and postdoctoral research as well as extramural research on Panchagavya are available to the interested scholars and scientists.
Medicines made from Cow’s products falling within the purview of Section 3(a) and Section (h) of drugs and Cosmetic Act, 1940 are regulated as in the case of Ayurvedic, Siddha and Unani medicines. The licensing and quality control provisions for such medicines are prescribed in the Drugs and Cosmetic Rules, 1945 and the standards are given in the Pharmacopeia. Details of cow shelter houses and other agencies engaged in the activities related to cow’s products are not maintained by the Ministry of AYUSH since the enforcement of the relevant legal provisions is done by the state authorities.
This information was given by the Minister of State (Independent Charge) for AYUSH, Shri ShripadYesso Naik in written reply to a question in Lok Sabha today.
*************
AYUSH
25-November, 2016 14:36 IST
Government following international quality control & quality certification practices to boost export of Ayurveda products: Shri Shripad Naik
Central Government issued directions in September, 2007 to the State Governments under Section 33-P of the Drugs & Cosmetics Act, 1940 to streamline the system for licensing of patent & proprietary Ayurveda, Siddha and Unani Products under Rule 154 and 154-A of the Drugs & Cosmetics Rules, 1945 by constituting an Expert Committee under the chairmanship of Commissioner/Director (Indian Systems of Medicine) of the State as per the provisions of the Rule 154(2) for advising the State Licensing Authority before any patent & proprietary Ayurvedic, Siddha or Unani Medicine is licensed for production by any manufacturing unit.
There is no grading system for AYUSH products except categorization as classical formulations and patent & proprietary medicines as defined in Section 3(a) and (h) of the Drugs & Cosmetics Act, 1940. Homeopathic medicines have different potencies depending upon the extent of dilution of mother tincture.
Quality standards of Ayurvedic, Siddha, Unani and Homeopathic drugs are prescribed in respective pharmacopoeias published by the Government. Ayurvedic pharmacopoeia contains 645 monographs of single drugs and 202 monographs of compound formulations; Unani Pharmacopoeia contains 298 monographs of single drugs and 150 monographs of compound formulations; Siddha pharmacopoeia contains 139 monographs of single drugs and Homeopathic Pharmacopoeia has 1117 monographs. Provisions for quality control of Ayurvedic, Siddha, Unani and Homeopathic drugs are provided in Drugs & Cosmetics Act, 1940 and Rules thereunder.
For enhancing export of the Ayurvedic products, compliance to Good Manufacturing Practices has been made mandatory for the manufacturers and quality certification system as per WHO guidelines is administered by Central Drugs Standard Control Organization and similarly AYUSH Standard Mark and AYUSH Premium Mark certification system is implemented by Quality Council of India. Through the Central Scheme of International Cooperation implemented by the Ministry of AYUSH, financial support is provided for preparation of product dossier, registration of products in foreign countries and for participation of AYUSH drugs manufacturers in the International Trade Fairs, Exhibitions and Road shows.
This information was given by the Minister of State (Independent Charge) for AYUSH, Shri ShripadYesso Naik in written reply to a question in Lok Sabha today.
………………
………………
AYUSH
25-November, 2016 14:34 IST
Government is formulating AYUSH drugs for prevention and management of vector borne diseases: Shri Shripad Naik
The Central Government has set up four Research Councils, namely Central Council for Research in Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Siddha (CCRS) and Central Council for Research in Homoeopathy (CCRH) which are involved in research activities, inter-alia including development/formulation of new drugs. CCRAS has formulated Ayush 64, a poly herbal, anti malarial drug.
(i) CCRAS has recently developed AYUSH SL, a new Ayurvedic drug for filarisis; and AYUSH PJ7 for dengue. Pre-clinical studies for AYUSH SL has been completed. Pre-clinical studies for AYUSH PJ7 has been completed.
(ii) CCRAS has further made deliberations for conducting clinical studies with Indian Council of Medical Research(ICMR) to counter diseases like dengue.
(iii) Further, CCRUM has made observational studies on the efficacy of some Unani drugs in the vector borne diseases, viz., Malaria, filarisis and Kala Azar which has showed significant therapeutic effects in subsiding different signs and symptoms in these conditions.
(iv) CCRH has conducted preventive studies on dengue and chikungunya. Clinical management studies on dengue, Japanese encephalitis and acute lymphadenitis due to filariasis have already been conducted by CCRH.
(v) The Central Research Councils have developed guidelines for management and prevention of dengue, chickungunya with their respective system of medicine to counter dengue and chickungunya. Wide publicity through prominent newspapers have been carried by these councils during July, 2016 to October, 2016. CCRH has also developed guidelines for prevention and management in the case of Japanese encephalitis.
This information was given by the Minister of State (Independent Charge) for AYUSH, Shri ShripadYesso Naik in written reply to a question in Lok Sabha today.
………………